# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Sharps Technology shares are trading higher Thursday after the company announced it has received a signed $30 million purchase ...
Signed PO secures first 12 months of syringe product orders against Sharps and Nephron's five-year, $200 million Syringe Sa...
InjectEZ acquisition establishing Sharps position in the prefillable syringe (PFS) industry in the U.S. has progressed with the...